Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Gemphire Therapeutics seeks evidence for gemcabene as treatment for pediatric nonalcoholic fatty liver disease
January 31, 2018 Off

Gemphire Therapeutics seeks evidence for gemcabene as treatment for pediatric nonalcoholic fatty liver disease

By Dino Mustafić

Gemphire Therapeutics, a US based clinical-stage biopharmaceutical company focused on therapies for cardiometabolic disorders, including dyslipidemia and Nonalcoholic Steatohepatitis (NASH), has…

Filament, University of Ottawa, CHEO partner up in $7.4M project funded by Genome Canada and CIHR to study inflammatory bowel disease treatment
January 31, 2018 Off

Filament, University of Ottawa, CHEO partner up in $7.4M project funded by Genome Canada and CIHR to study inflammatory bowel disease treatment

By Dino Mustafić

Filament BioSolutions, a New York-based clinical nutrition therapeutics specialist from announced a collaboration with the University of Ottawa and Children’s…

AIT Therapeutics acquires license to eNOGenerator from NitricGen for $2M plus milestones
January 31, 2018 Off

AIT Therapeutics acquires license to eNOGenerator from NitricGen for $2M plus milestones

By Dino Mustafić

AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients…

January 31, 2018 Off

Sanofi asks EMA to review drug for sleeping sickness

By Dino Mustafić

Sanofi has asked the European Medicines Agency (EMA) to review fexinidazole for the treatment of sleeping sickness. Fexinidazole is being…

January 31, 2018 Off

Boehringer Ingelheim appoints new CEO

By Dino Mustafić

Boehringer Ingelheim has appointed new CEO Wednesday, who will replace Paul Fonteyne,  as he will retire after 15 years, on December…

Nuformix wraps up pilot study for its NXP002 for treating fibrosis
January 31, 2018 Off

Nuformix wraps up pilot study for its NXP002 for treating fibrosis

By Dino Mustafić

Nuformix has completed pilot pre-clinical studies that further validate the potential for its NXP002 programme in successfully and safely treating…

January 31, 2018 Off

Albiero Pharma completes public offering, $69.9 million net

By Dino Mustafić

Boston-based Albireo Pharma, a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, has completed its public offering of…

Romastru brings Amryt’s cholesterol treatment Lojuxta to Romania and Bulgaria
January 30, 2018 Off

Romastru brings Amryt’s cholesterol treatment Lojuxta to Romania and Bulgaria

By Dino Mustafić

Amryt has signed an exclusive distribution agreement for Lojuxta (lomitapide) covering Romania and Bulgaria with Romastru Trading SRL (Romastru), a…

Beximco increases profit in Q2 2017
January 30, 2018 Off

Beximco increases profit in Q2 2017

By Dino Mustafić

The London-listed Bangladesh-based pharmaceutical company, Beximco, has had net sales in the second quarter increased 12.8% to BDT 4,359.9m /…

AB Biosciences, Shire in licence deal
January 30, 2018 Off

AB Biosciences, Shire in licence deal

By Dino Mustafić

AB Biosciences will grant Shire an exclusive worldwide license to develop and commercialize AB Biosciences’ pan receptor interacting molecule (PRIM)…

Posts pagination

Previous 1 … 3,410 3,411 3,412 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine